Publications & Reports

Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia.

Hellard ME, Jenkinson R, Higgs P, Stoové MA, Sacks-Davis R, Gold J, Hickman M, Vickerman P, Martin NK
Centre for Population Health, Burnet Institute, Melbourne, VIC, Australia. hellard@burnet.edu.au.

Abstract

OBJECTIVES: This model suggests that modest rates of current HCV treatment among PWID in Victoria, Australia could halve HCV infection prevalence among PWID in 30 years. This finding suggests that interventions aimed at increasing access to HCV treatment in community clinics will benefit individual PWID and reduce HCV infection prevalence.

Publication

  • Journal: The Medical Journal of Australia
  • Published: 08/06/2012
  • Volume: 196
  • Issue: 10
  • Pagination: 638-641

Authors

Health Issue